Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model.

Abstract

BACKGROUND Adiponectin plays a protective role in the development of obesity-linked disorders. We demonstrated that adiponectin exerts beneficial actions on acute ischemic injury in mice hearts. However, the effects of adiponectin treatment in large animals and its feasibility in clinical practice have not been investigated. This study investigated the effects of intracoronary administration of adiponectin on myocardial ischemia-reperfusion (I/R) injury in pigs. METHODS AND RESULTS The left anterior descending coronary artery was occluded in pigs for 45 minutes and then reperfused for 24 hours. Recombinant adiponectin protein was given as a bolus intracoronary injection during ischemia. Cardiac functional parameters were measured by a manometer-tipped catheter. Apoptosis was evaluated by terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling staining. Tumor necrosis factor-alpha and interleukin-10 transcripts were analyzed by real-time polymerase chain reaction. Serum levels of derivatives of reactive oxygen metabolites and biological antioxidant potential were measured. Adiponectin protein was determined by immunohistochemical and Western blot analyses. Intracoronary administration of adiponectin protein led to a reduction in myocardial infarct size and improvement of left ventricular function in pigs after I/R. Injected adiponectin protein accumulated in the I/R-injured heart. Adiponectin treatment resulted in decreased tumor necrosis factor-alpha and increased interleukin-10 mRNA levels in the myocardium after I/R. Adiponectin-treated pigs had reduced apoptotic activity in the I/R-injured heart and showed increased biological antioxidant potential levels and decreased derivatives of reactive oxygen metabolite levels in the blood stream after I/R. CONCLUSIONS These data suggest that adiponectin protects against I/R injury in a preclinical pig model through its ability to suppress inflammation, apoptosis, and oxidative stress. Administration of intracoronary adiponectin could be a useful adjunctive therapy for acute myocardial infarction.

DOI: 10.1161/CIRCINTERVENTIONS.109.872044

7 Figures and Tables

0204020102011201220132014201520162017
Citations per Year

90 Citations

Semantic Scholar estimates that this publication has 90 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Kondo2010ImpactOA, title={Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model.}, author={Kazuhisa Kondo and Rei Shibata and Kazumasa Unno and Masayuki Shimano and Masakazu Ishii and Tetsutaro Kito and Satoshi Shintani and Kenneth Walsh and Noriyuki Ouchi and Toyoaki Murohara}, journal={Circulation. Cardiovascular interventions}, year={2010}, volume={3 2}, pages={166-73} }